Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
Sponsor: Novo Nordisk A/S
Summary
This study will look at how well CagriSema helps people with excess body weight lose weight. CagriSema is a new medicine developed by Novo Nordisk that combines cagrilintide and semaglutide. CagriSema cannot yet be prescribed by doctors. In the study, participant will either get CagriSema or dummy medicine and which treatment participant get is decided by chance. The study will last for about 1½ years for each participant.
Official title: Efficacy and Safety of Cagrilintide s.c. in Combination With Semaglutide s.c.(CagriSema s.c. 1.0 mg/1.0 mg and 1.7 mg/1.7 mg) Once-weekly in Participants With Overweight or Obesity
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2024-06-24
Completion Date
2026-04-21
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Interventions
Cagrilintide
Participants will receive once-weekly cagrilintide subcutaneously.
Semaglutide
Participants will receive once-weekly semaglutide subcutaneously.
Placebo
Participants will receive once-weekly placebo matched to cagrilintide and semaglutide subcutaneously.
Locations (25)
Aurora FDRC Inc.
Costa Mesa, California, United States
Clinical Trial Res Assoc,Inc
Plantation, Florida, United States
Midwest Inst For Clin Res
Indianapolis, Indiana, United States
Accellacare
Wilmington, North Carolina, United States
Velocity Clinical Res-Dallas
Dallas, Texas, United States
Washington Cntr Weight Mgmt
Arlington, Virginia, United States
Capital Clin Res Ctr,LLC
Olympia, Washington, United States
Ocean West Research Clinic
Surrey, British Columbia, Canada
Nova Scotia Health Authority
Halifax, Nova Scotia, Canada
Wharton Med Clin Trials
Hamilton, Ontario, Canada
Hospices Civils de Lyon-Hopital Lyon Sud-1
Pierre-Bénite, France
Hospices Civils de Lyon-Hopital Lyon Sud
Pierre-Bénite, France
Centre Hospitalier Universitaire de Nantes-Hopital Nord Laennec
Saint-Herblain, France
Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil
Toulouse, France
InnoDiab Forschung GmbH
Essen, Germany
Wendisch - Dahl Hamburg - DZHW
Hamburg, Germany
AmBeNet GmbH
Leipzig, Germany
Institut für Diabetesforschung GmbH Münster - Dr. med. Rose
Münster, Germany
Forschungszentrum Ruhr KliFoCenter GmbH, Kahrmann
Witten, Germany
The Health Centre
Bradford-on-Avon, United Kingdom
Southmead Hospital
Bristol, United Kingdom
Addenbrooke's Hospital_Cambridge
Cambridge, United Kingdom
University Hospital Coventry - WISDEM Centre
Coventry, United Kingdom
Staploe Medical Centre
Soham, United Kingdom
Joint Clinical Research Facility - Swansea
Swansea, United Kingdom